Induran Ventures

About

Induran raises venture capital on a project by project basis to advance the profitable commercialization of technologies that demonstrate the potential to have a major impact on problems confronting humanity in the twenty-first century.

Canadian biotechnology is globally competitive. Canadian companies and research organizations generate world class research. We believe that the Canadian biotechnology sector is significantly underfunded and undervalued by the capital markets.

Our team balances the deep experience of respected business leaders, high net worth individuals, leading academics and researchers, seasoned wealth managers and serial entrepreneurs with proven ability to grow enterprises. The team has been working together for over 10 years.

The enterprises we select are working with revolutionary yet practical innovations.


Source: Induran Ventures

Strategy

Induran looks for opportunities to create strong business models. The markets must be large and growing. The technology or product should be globally competitive.
The investment focus is on projects in biological science and engineering. Our typical fund size ranges from $5M to $15M.


Source: Induran Ventures


  • Industry Focus
    Biotechnology
  • Year Founded
    2012
  • Address
    150 William Street
    Kingston, Ontario, Canada
    K7L 2C9
  • Key Personnel
    J. Peter Blaney – CEO
    Dr. Thomas Racey
    William C. Leggett
    Barry Markowsky